Iovance Biotherapeutics, Inc. (IOVA)

Last Three Months

29-Jun-24 -- 28-Sep-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

20

0

4

+1

0

+2

0

+3

Two Year Chart

29-Sep-22 -- 28-Sep-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
05-Sep-24 7:54 PM View:	03-Sep-24 Payment of Exercise ($150.53K)	Graf Finckenstein Friedrich Chief Medical Officer		Iovance Biotherapeutics, Inc. - IOVA	33% 44.49K to 59.34K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 7:52 PM View:	03-Sep-24 Payment of Exercise ($129.02K)	Bellemin Jean-Marc Chief Financial Officer		Iovance Biotherapeutics, Inc. - IOVA	65% 17.8K to 29.35K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 7:53 PM View:	03-Sep-24 Payment of Exercise ($148.37K)	Bilinsky Igor Chief Operating Officer		Iovance Biotherapeutics, Inc. - IOVA	37% 39.76K to 54.42K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 7:56 PM View:	03-Sep-24 Payment of Exercise ($264.08K)	Vogt Frederick G Interim CEO & General Counsel Director		Iovance Biotherapeutics, Inc. - IOVA	31% 147.32K to 192.26K	0	0	--	--	Show Txns Hide Txns